Table of Contents
RETRACTED

This article has been retracted upon the authors' request, as it was found to include erroneous data that their findings and conclusions cannot be relied upon. Additionally, the article was submitted for publication by the author Gemina Doolub without the knowledge and approval of the other author Erica Dall'Armellina.

ISRN Cardiology
Volume 2013 (2013), Article ID 248476, 8 pages
http://dx.doi.org/10.1155/2013/248476
Clinical Study

Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?

1Cardiology Department, John Radcliffe Hospital, Oxford OX3 9DU, UK
2Oxford Centre for Clinical Magnetic Resonance, John Radcliffe Hospital, Oxford, UK

Received 4 February 2013; Accepted 7 March 2013

Academic Editors: Y. Hayabuchi and T. Ishimitsu

Copyright © 2013 Gemina Doolub and Erica Dall'Armellina. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Gemina Doolub and Erica Dall'Armellina, “Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?,” ISRN Cardiology, vol. 2013, Article ID 248476, 8 pages, 2013. doi:10.1155/2013/248476